Compare ARK Genomic Revolution ETF (ARKG) vs 3M Company (MMM) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs 3M Company — how do they compare? ARK Genomic Revolution ETF trades at $41.25, while 3M Company trades at $157.3 (market cap $82.16B). The key difference: 3M Company pays a 1.98% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, 3M Company nearer its low. Which is the better fit depends on your goals.
| ARKG | MMM | |
|---|---|---|
Sector | Sector/Thematic | Industrials |
52-Week High | $43.57 | $174.61 |
52-Week Low | $23.09 | $141.10 |
Market Cap | — | $82.16B |
Enterprise Value | — | $90.56B |
Dividend Yield | — | 1.98% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
3M (MMM) trades at $157.52, up 1.4% today, with a bearish technical signal despite recent earnings beats. The company shows strong profitability with a 72.14% ROE and 13.03% net margin, though revenue has declined from 2022 peaks. Recent news highlights segment weakness in Consumer but strength in Safety & Industrial, alongside strategic partnerships like the Airbus A220 supply agreement.
Outlook is mixed: analyst consensus is cautious with a $148.75 price target below current levels, citing persistent consumer segment challenges. Investment appeal lies in dividend yield and cost optimization efforts, but risks include revenue stagnation and high debt levels. The stock faces headwinds from technical bearishness and modest growth projections.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About 3M Company
3M Company conducts operations in electronics, telecommunications, industrial, consumer and office, health care, safety, and other markets. The Company businesses share technologies, manufacturing operations, marketing channels, and other resources. 3M serves customers worldwide.
Read more on MMM →
